Offering support and advice to people working in harm reduction services (especially needle programmes) and to people who inject drugs since 2007.
I’ve been fortunate to have been given access to photograph at the two Drug Consumption Rooms in Australia, the Sydney Medically Supervised Injecting Centre (MSIC) which has been running for over 17 years, and the recently opened Melbourne Medically Supervised Injecting Room (MSIR). Most of the photos I’ve been taking are of the staff and the facilities at the projects… but I’d like to describe the photo I didn’t take.
Link opens on my photography site
The latter half of 2016 saw increased interest and positive development with regard to the introduction of Safer Injecting Facilities (SIF) in both Scotland and the Republic of Ireland. Whether or not this interest proves to be yet another false policy promise in the progress of UK harm reduction remains to be seen. However, during this period of potential development, I couldn’t help but notice that advocates of SIF stated that such facilities would aim to reduce local levels of ‘public injecting’ and assist with ‘removing drug-use from the street’.
Training & Consultancy
Nigel Brunsdon has been delivering harm reduction focused training for over a decade to some of the biggest drug service providors in the UK. All courses are focused on practical skills and can be delivered to delegates at any existing knowledge level.
Back in June I released the NSP Outcomes Tool This was an attempt to make a simple to use but flexible assessment/review tool that could be used in the relatively short time that most needle transactions happen in. Because of the need to make it so simple it unfortunately didn’t include anything around the use of steroids and other performance/image enhancing drugs (PIEDs). So now I’ve designed a NSP tool specifically for use with PIED users.
The Advisory Council of the Misuse of Drugs (ACMD) has reviewed the evidence on the provision and availability of naloxone in the UK, a medicine which can temporarily reverse the effects of opioids and is used as an emergency treatment for people who overdose on these drugs. The findings of this review, and recommendations to optimise the use of naloxone are presented in this report.